Syngene International Limited (NSE: SYNGENE)
India
· Delayed Price · Currency is INR | Market Cap | 339.84B |
| Revenue (ttm) | 34.51B |
| Net Income (ttm) | 4.82B |
| Shares Out | 401.28M |
| EPS (ttm) | 12.00 |
| PE Ratio | 70.56 |
| Forward PE | 56.46 |
| Dividend | 1.25 (0.15%) |
| Ex-Dividend Date | Jun 28, 2024 |
| Volume | 151,350 |
| Open | 848.00 |
| Previous Close | 850.80 |
| Day's Range | 839.55 - 854.65 |
| 52-Week Range | 607.65 - 945.25 |
| Beta | 0.58 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jan 21, 2025 |
About Syngene International
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, prot... [Read more]
Financial Performance
In 2023, Syngene International's revenue was 34.89 billion, an increase of 9.26% compared to the previous year's 31.93 billion. Earnings were 5.10 billion, an increase of 9.82%.
Financial StatementsNews
Syngene International’s market cap decreases by Rs 760 crore as shares drop 2.19% today – Know More
Shares of Syngene International Limited fell by 2.19% today, closing at Rs 842.75, down from the previous close of Rs 861.60. The decline led to an estimated market capitalization loss of Rs 760 crore...